Controversies in Testosterone Treatment 2020 in Cisgender and Transgender Men
Todd T. Brown, MD, PhD
Professor of Medicine
Johns Hopkins Hospital
Baltimore, MD
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc. Copyright © 2020. All rights reserved.
Todd Brown is the primary endocrine consultant to the Johns Hopkins HIV Clinic. His research focuses on metabolic, endocrine, and skeletal abnormalities observed in HIV-infected patients. He is the co-chair of the Executive Committee of the MACS WIHS Combined Cohort Study and has served in leadership positions for the ACTG. He has mentored multiple trainees from across the country and around the world in the area of HIV Comorbidities and Aging. He has published widely on the topic of HIV and endocrine conditions and lectures internationally on this and other issues related to metabolic diseases in HIV.
At the completion of this educational session, learners will:
- Understand the potential risks and benefits of testosterone treatment in the older cisgender male.
- Be familiar with the findings of the T Trials and the clinical questions that still remain.
- Understand what is known about the risks of testosterone for gender-affirming therapy in transgender men.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare
Download Article PDF/Slides